Tomuzotuximab Uses, Dosage, Side Effects and more

Tomuzotuximab is under investigation in clinical trial NCT02052960 (CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer).

Trade Name Tomuzotuximab
Generic Tomuzotuximab
Tomuzotuximab Other Names Tomuzotuximab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share